Bratton Capital Management, L.P.

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), Bratton Capital Management, L.P. reported 1 stock position worth $41.8 million. Its top holding was Aquestive Therapeutics (AQST) at 100.0% of the portfolio. Its holdings were unchanged from Q4 2023.

Most Recent 13F
Q2 2026
Location
FORT WORTH, TX
CIK
0001723787
Portfolio Value
$41.8M (Q1 2024)
SEC Filing
0001315863-24-000462 ↗ filed May 14, 2024

Holdings Value

0$20.0M$40.0M$60.0M$80.0M Q1 2024: $41.8M $41.8M Q1 2024 Q2 2024: $25.5M Q2 2024 Q3 2024: $48.9M Q3 2024 Q4 2024: $34.9M Q4 2024 Q1 2025: $28.5M Q1 2025 Q2 2025: $32.5M Q2 2025 Q3 2025: $54.8M Q3 2025 Q4 2025: $63.4M Q4 2025 Q1 2026: $40.7M Q1 2026 Q2 2026: $40.8M Q2 2026

Holdings 1 stocks · $41.8M
AQST Aquestive Therapeutics Inc. 100.00% 9,810,958 $41.8M No change

Portfolio Sells Q4 2023 → Q1 2024
None this quarter.

Portfolio Buys Q4 2023 → Q1 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$40.8MAQST
Q1 2026 1$40.7MAQST
Q4 2025 1$63.4MAQST
Q3 2025 1$54.8MAQST
Q2 2025 1$32.5MAQST
Q1 2025 1$28.5MAQST
Q4 2024 1$34.9MAQST
Q3 2024 1$48.9MAQST
Q2 2024 1$25.5MAQST
Q1 2024 1$41.8MAQST